Intellipharmaceutics International, Inc. (IPCIQ)
0.0000
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Intellipharmaceutics International Max Drawdown (5Y) : 100.00% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 100.00% |
| June 30, 2026 | 100.00% |
| May 31, 2026 | 100.00% |
| April 30, 2026 | 100.00% |
| March 31, 2026 | 100.00% |
| February 28, 2026 | 100.00% |
| January 31, 2026 | 100.00% |
| December 31, 2025 | 100.00% |
| November 30, 2025 | 100.00% |
| October 31, 2025 | 100.00% |
| September 30, 2025 | 100.00% |
| August 31, 2025 | 100.00% |
| July 31, 2025 | 100.00% |
| June 30, 2025 | 100.00% |
| May 31, 2025 | 100.00% |
| April 30, 2025 | 100.00% |
| March 31, 2025 | 100.00% |
| February 28, 2025 | 100.00% |
| January 31, 2025 | 100.00% |
| December 31, 2024 | 100.00% |
| November 30, 2024 | 100.00% |
| October 31, 2024 | 100.00% |
| September 30, 2024 | 100.00% |
| August 31, 2024 | 100.00% |
| July 31, 2024 | 100.00% |
| Date | Value |
|---|---|
| June 30, 2024 | 99.98% |
| May 31, 2024 | 99.98% |
| April 30, 2024 | 99.98% |
| March 31, 2024 | 99.98% |
| February 29, 2024 | 99.98% |
| January 31, 2024 | 99.98% |
| December 31, 2023 | 99.98% |
| November 30, 2023 | 99.98% |
| October 31, 2023 | 99.98% |
| September 30, 2023 | 99.98% |
| August 31, 2023 | 99.98% |
| July 31, 2023 | 99.98% |
| June 30, 2023 | 99.98% |
| May 31, 2023 | 99.98% |
| April 30, 2023 | 99.77% |
| March 31, 2023 | 99.77% |
| February 28, 2023 | 99.77% |
| January 31, 2023 | 99.77% |
| December 31, 2022 | 99.77% |
| November 30, 2022 | 99.77% |
| October 31, 2022 | 99.77% |
| September 30, 2022 | 99.77% |
| August 31, 2022 | 99.77% |
| July 31, 2022 | 99.77% |
| June 30, 2022 | 99.77% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Abattis Bioceuticals Corp. | 100.00% |
| InMed Pharmaceuticals, Inc. | 99.97% |
| Tetra Bio-Pharma, Inc. | 100.00% |
| NervGen Pharma Corp. | 73.37% |
| Milestone Pharmaceuticals, Inc. | 95.25% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -105.95 |
| Beta (5Y) | 1.218 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 498.6% |
| Historical Sharpe Ratio (5Y) | -0.19 |
| Historical Sortino (5Y) | -1.484 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 33.37% |